Today: The Amsurg Corp. (AMSG) Receives “Positive” Rating from KeyCorp

The Amsurg Corp. (AMSG) Receives “Positive” Rating from KeyCorp

KeyCorp reiterated their positive rating on shares of Amsurg Corp. (NASDAQ:AMSG) in a research report sent to investors on Tuesday morning. KeyCorp currently has a $87.00 target price on the stock.

AMSG has been the topic of several other research reports. Zacks Investment Research raised Amsurg Corp. from a hold rating to a buy rating and set a $88.00 price target on the stock in a research report on Monday, July 11th. Wells Fargo & Co. started coverage on Amsurg Corp. in a report on Tuesday, June 14th. They issued a market perform rating on the stock. Robert W. Baird reissued a buy rating on shares of Amsurg Corp. in a report on Thursday, June 16th. Goldman Sachs Group Inc. reissued a buy rating on shares of Amsurg Corp. in a report on Friday, June 17th. Finally, Citigroup Inc. started coverage on Amsurg Corp. in a report on Monday, September 26th. They issued a buy rating and a $79.00 target price on the stock. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company presently has an average rating of Buy and an average target price of $92.09.

Shares of Amsurg Corp. (NASDAQ:AMSG) traded up 1.20% on Tuesday, hitting $66.58. The stock had a trading volume of 279,181 shares. Amsurg Corp. has a 12 month low of $58.37 and a 12 month high of $87.29. The stock has a market cap of $3.58 billion, a P/E ratio of 19.76 and a beta of 0.68. The firm has a 50 day moving average of $65.43 and a 200 day moving average of $73.44.

Amsurg Corp. (NASDAQ:AMSG) last released its quarterly earnings results on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.08 by $0.02. The company had revenue of $758.50 million for the quarter, compared to analyst estimates of $769.88 million. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. The firm’s revenue was up 21.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.97 earnings per share. On average, equities analysts forecast that Amsurg Corp. will post $4.33 earnings per share for the current fiscal year.

In other Amsurg Corp. news, insider Robert Jon Coward sold 7,500 shares of the business’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $63.65, for a total transaction of $477,375.00. Following the sale, the insider now directly owns 97,507 shares in the company, valued at $6,206,320.55. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 2.30% of the company’s stock.

Hedge funds have recently bought and sold shares of the company. Calvert Investment Management Inc. increased its stake in shares of Amsurg Corp. by 0.9% in the second quarter. Calvert Investment Management Inc. now owns 3,180 shares of the company’s stock valued at $247,000 after buying an additional 29 shares in the last quarter. Howe & Rusling Inc. increased its stake in shares of Amsurg Corp. by 0.8% in the second quarter. Howe & Rusling Inc. now owns 8,695 shares of the company’s stock valued at $674,000 after buying an additional 65 shares in the last quarter. Northwestern Mutual Investment Management Company LLC increased its stake in shares of Amsurg Corp. by 1.0% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 9,334 shares of the company’s stock valued at $724,000 after buying an additional 93 shares in the last quarter. GHP Investment Advisors Inc. increased its stake in shares of Amsurg Corp. by 1.0% in the second quarter. GHP Investment Advisors Inc. now owns 15,875 shares of the company’s stock valued at $1,231,000 after buying an additional 155 shares in the last quarter. Finally, Raymond James Trust N.A. increased its stake in shares of Amsurg Corp. by 4.6% in the second quarter. Raymond James Trust N.A. now owns 5,042 shares of the company’s stock valued at $391,000 after buying an additional 223 shares in the last quarter. Institutional investors own 98.42% of the company’s stock.

About Amsurg Corp.

Related posts

Leave a Comment